Kiniksa Pharmaceuticals
Mei Huei Jang possesses extensive experience in technical operations within the pharmaceutical industry. Current roles include Senior Vice President of Technical Operations and Group Vice President of Technical Operations at Kiniksa Pharmaceuticals, as well as a previous position as Vice President of CMC. Prior roles include Director of Downstream Development and Operations at TESARO, Inc., Associate Director and CMC and Downstream Development Lead at Shire HGT, and Scientist at RenaMed Biologics, Inc. Mei Huei Jang holds a PhD in Biochemistry from The Ohio State University.
This person is not in any teams
Kiniksa Pharmaceuticals
2 followers
Kiniksa is a publicly traded biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.